跳至主要内容
临床试验/IRCT20191223045862N1
IRCT20191223045862N1已完成3 期

The effect of oral supplementation of zinc on glycemic status, lipid profile and body composition in non-diabetic hemodialysis patients

Oroumia University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • At least 6 months have passed since the start of hemodialysis.
  • Patients undergo hemodialysis 3 times a week for 4-3 hours.
  • Non-diabetic hemodialysis patients

排除标准

  • Patients are candidates for kidney transplant.
  • Patients with any symptoms of gastrointestinal disorders.
  • Patients taking penicillamine medication.
  • Patients taking glucocorticoid medication.
  • Patients taking estrogen medication.
  • Patients taking the antibiotic medication.
  • Women taking oral contraceptives.
  • Patients taking lipid lowering medications.
  • Patients with zinc malabsorption (Acroderma enteropathica).
  • Pregnant and lactating women.

研究者

发起方
Oroumia University of Medical Sciences

相似试验